HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Developmental toxicity of the HIV-protease inhibitor indinavir in rats.

AbstractBACKGROUND:
Indinavir is an antiviral agent used for the treatment of HIV infection. We studied its developmental toxicity in rats.
METHODS:
Pregnant animals were treated orally with 500 mg indinavir/kg body weight (bw) from day 6 to 15 of gestation (once daily) or from day 9 to 11 (twice daily). Fetuses were evaluated for external and skeletal anomalies on day 21 of gestation. In addition, 19 rats were treated from day 9 of gestation to day 24 postnatally with 500 mg indinavir/kg bw once daily; a control group of 17 rats was treated with the vehicle accordingly. Developmental landmarks were recorded. Sixteen offspring each were studied on postnatal days 7, 14, 21, and 35 for hepatic enzyme activity. Liver tissue was examined by electron microscopy.
RESULTS:
Fetal examination on day 21 of pregnancy showed no treatment-related effects on number, weight, and viability of the fetuses; however, an increased incidence was noted in the supernumerary ribs and variations of the vertebral ossification centers in both indinavir-treated groups. Postnatal evaluation showed delayed fur development, eye opening, and descensus testis. The most striking finding was unilateral anophthalmia, observed in 7 pups (3%) from 2 out of 19 litters exposed to indinavir, but not in controls. Only minor changes in hepatic monooxygenase activities occurred in dams. Electron microscopy of liver samples showed hepatocellular inclusions of lipids and myelin figure-like structures in maternal livers and infiltration with granulocytes in offspring livers.
CONCLUSIONS:
Further studies on reproductive toxicity, including combinations of three or more antiretroviral agents as used therapeutically, are needed to determine the hazards of such a treatment.
AuthorsK Riecke, T G Schulz, M Shakibaei, B Krause, I Chahoud, R Stahlmann
JournalTeratology (Teratology) Vol. 62 Issue 5 Pg. 291-300 (Nov 2000) ISSN: 0040-3709 [Print] UNITED STATES
PMID11029147 (Publication Type: Journal Article)
CopyrightCopyright 2000 Wiley-Liss, Inc.
Chemical References
  • HIV Protease Inhibitors
  • Indinavir
  • Cytochrome P-450 Enzyme System
Topics
  • Abnormalities, Drug-Induced (enzymology, etiology)
  • Animals
  • Anophthalmos (chemically induced)
  • Body Weight (drug effects)
  • Cytochrome P-450 Enzyme System (metabolism)
  • Dose-Response Relationship, Drug
  • Embryonic and Fetal Development (drug effects)
  • Female
  • Fetus (drug effects, pathology)
  • HIV Protease Inhibitors (toxicity)
  • Indinavir (toxicity)
  • Liver (drug effects, metabolism, ultrastructure)
  • Male
  • Microscopy, Electron
  • Microsomes, Liver (drug effects, metabolism)
  • Ossification, Heterotopic (chemically induced)
  • Pregnancy
  • Rats
  • Rats, Wistar
  • Ribs (abnormalities)
  • Spine (abnormalities, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: